First Edition: Nov. 23, 2022


Today’s early morning highlights from the major news organizations. Note to readers: KHN’s First Edition is off for the rest of the week. Check for it next in your inbox on Nov. 28. Happy Thanksgiving!


KHN:
Trickle Of Covid Relief Funds Helps Fill Gaps In Rural Kids’ Mental Health Services 


The Mary Hill Youth and Family Center’s building has long been at a crossroads overlooking this rural Appalachian city, but its purpose has evolved. For 65 years, residents of Nelsonville and the rolling hills of southeastern Ohio traveled to the hilltop hospital seeking care. Then, in 2014, the 15-bed hospital, which was often without patients, closed. (Saint Louis, 11/23)


KHN:
A Work-From-Home Culture Takes Root In California 


Even as pandemic lockdowns fade into memory, covid-19 has transformed California’s workplace culture in ways researchers say will reverberate well beyond 2022. According to new data from the U.S. Census Bureau, working from home for some portion of the week has become the new normal for a large segment of Californians. The data shows high-income employees with college degrees are more likely to have access to this hybrid work model, while lower-income employees stay the course with on-site responsibilities and daily commutes. (Reese, 11/23)


Politico:
Fauci Bids Farewell With A Final Plea: Get Vaccinated 


Anthony Fauci, the president’s chief Covid-19 adviser, offered Americans one final warning as he prepares to leave government, ending a tumultuous turn in the national spotlight that earned him enduring affection from some and unrelenting hostility from others. “Please, for your own safety, for that of your family, get your updated Covid-19 shot as soon as you’re eligible to protect yourself, your family and your community,” Fauci said. (Mahr and Cancryn, 11/22)


Reuters:
Fauci Pleads With Americans To Get COVID Shot In Final White House Briefing 


After 13 billion doses of COVID-19 vaccines given worldwide, Fauci said, there is “clearly an extensive body of information” that indicates that they are safe. “When I see people in this country because of the divisiveness in our country … not getting vaccinated for reasons that have nothing to do with public health, but have to do because of divisiveness and ideological differences, as a physician, it pains me,” Fauci said. (Holland and Hunnicutt, 11/22)


The New York Times:
Fauci Sees A Reduced Covid Threat This Winter


While the trajectory of the virus remains uncertain, Dr. Anthony S. Fauci, President Biden’s chief medical adviser, said the administration was hopeful that the combination of infections and vaccinations had created “enough community protection that we’re not going to see a repeat of what we saw last year at this time” when a brand-new variant, Omicron, emerged seemingly out of the blue. (LaFraniere and Mueller, 11/22)


Reuters:
White House’s Jha: Social Media Platform Owners Should Consider Role In COVID Misinformation


Owners of social media platforms should consider their personal responsibility regarding health disinformation, and the public should choose reputable sources to trust, White House COVID-19 response coordinator Ashish Jha said on Tuesday. “You can decide to trust America’s physicians, or you can trust some random dude on Twitter. Those are your choices,” Jha said at a White House press briefing. (11/22)


The New York Times:
How Covid Myths Spread On Far-Right Social Media Platforms 


Not long after Randy Watt died of Covid-19, his daughter Danielle sat down at her computer, searching for clues as to why the smart and thoughtful man she knew had refused to get vaccinated. She pulled up Google, typed in a screen name he had used in the past and discovered a secret that stunned her. Her father, she learned, had a hidden, virtual life on Gab, a far-right social media platform that traffics in Covid misinformation. And there was another surprise as well: As he fought the coronavirus, he told his followers that he was taking ivermectin, a drug used to treat parasitic infections that experts say has no benefit — and in fact can be dangerous — for patients with Covid-19. (Stolberg, 11/22)


Axios:
ACA Sign-Ups Expected To Reach Record High, Becerra Says


Enrollment in Affordable Care Act marketplaces is on pace to set a new record, Health Secretary Xavier Becerra told Axios on Tuesday, with subsidies that Congress renewed through 2025 softening the blow of premium increases. early 3.4 million people have signed up for individual coverage between from Nov, 1 to 19 — a 17% increase from last year, according to HHS data. The number of new enrollees is also up 40%. (Gonzalez, 11/22)


AP:
Boost In People Seeking HealthCare.Gov Coverage, HHS Says 


The Biden administration announced Tuesday that it’s seeing a big uptick in the number of new customers buying private health insurance for 2023 from the Affordable Care Act’s marketplace. Nearly 3.4 million people have signed up for coverage — an increase of 17% compared to the same time last year. The boost in enrollment comes as the number of uninsured Americans this year reached a historic low of 8%. (Seitz, 11/22)


Politico:
WHO To Rename Monkeypox As ‘MPOX’


The World Health Organization is planning to rename monkeypox, designating it as “MPOX” in an effort to destigmatize the virus that gained a foothold in the U.S. earlier this year, three people with knowledge of the matter told POLITICO. The decision, which could be announced as early as Wednesday, follows an initial agreement the WHO made over the summer to consider suggestions for monkeypox’s new name. (Cancryn, 11/22)


Stat:
Analysis: One Dose Of Monkeypox Vaccine Yields Strong Protection


An analysis released Tuesday by U.K. health officials indicates that even one dose of the monkeypox vaccine provides strong protection against the virus. Researchers at the U.K. Health Security Agency estimated that one dose of the vaccine was 78% effective at protecting against infection 14 or more days after vaccination. (Joseph, 11/22)


Bloomberg:
World’s Most Expensive Drug Approved to Treat Hemophilia at $3.5 Million a Dose


“While the price is a little higher than expected, I do think it has a chance of being successful because 1) existing drugs are also very expensive and 2) hemophilia patients constantly live in fear of bleeds,” said Brad Loncar, a biotechnology investor and chief executive officer of Loncar Investments. “A gene therapy product will be appealing to some.” (Cortez, 11/23)


AP:
$3.5M Gene Therapy For Hemophilia Gets FDA Approval


The Food and Drug Administration cleared Hemgenix, an IV treatment for adults with hemophilia B, the less common form of the genetic disorder which primarily affects men. Currently, patients receive frequent, expensive IVs of a protein that helps blood clot and prevent bleeding. Drugmaker CSL Behring announced the $3.5 million price tag shortly after the FDA approval, saying its drug would ultimately reduce health care costs because patients would have fewer bleeding incidents and need fewer clotting treatments. The price appeared to exceed that of several other gene therapies priced upwards of $2 million. (Perrone, 11/22)


Roll Call:
New Booster Shots Cut Risk Of Symptomatic COVID-19 


The new bivalent COVID-19 booster shots are up to 56 percent more effective at preventing symptomatic COVID-19 infection than the two original COVID-19 vaccines in adults ages 18 and up, according to new data from the Centers for Disease Control and Prevention. (Cohen and Clason, 11/22)


Stat:
Real-World Data Show New Covid Boosters Increase Protection


The updated Covid-19 boosters increase people’s protection against symptomatic infection from the coronavirus, according to some of the first estimates of how the shot is performing in the real world and in people, not just in lab experiments. What’s more, that protection was even stronger when people waited a longer period of time since their last dose of the original shot. (Joseph, 11/22)


San Francisco Chronicle:
Stanford Seeks 200 Volunteers With Long COVID To Test Paxlovid, In Nation’s First Such Study


Stanford Medicine is seeking volunteers for the nation’s first clinical trial looking at whether the antiviral drug Paxlovid can fight one of COVID-19’s thorniest problems affecting millions of people: the long-term, debilitating suite of symptoms known as long COVID. There are currently no treatments, and many people turn to risky, unproven methods to try to cure themselves. (Asimov, 11/22)


NPR:
Experts Are Concerned Thanksgiving Gatherings Could Accelerate A ‘Tripledemic’


Of course, COVID-19 is still sickening tens of thousands and killing hundreds of people every day. And new, even more contagious omicron subvariants that are especially adept at infecting people — even if they’ve been vaccinated or previously infected — are taking over. “There’s a lot of moving parts here,” says Dr. David Rubin, who’s been tracking the pandemic at the PolicyLab at the Children’s Hospital of Philadelphia. (Stein, 11/23)


The New York Times:
How Immunocompromised Experts Will Celebrate Another Pandemic Holiday 


At the beginning of the coronavirus pandemic, Dr. Linda Yancey set a strict rule for her family: No relatives were allowed to go over to Grandma’s house until they could do so without risking her life. As an infectious-disease specialist at Memorial Hermann Health System in Houston, Dr. Yancey was keenly aware that her mother-in-law’s emphysema put her at high risk of hospitalization or even death if she got Covid. By 2021, Dr. Yancey’s mother-in-law was able to be fully vaccinated. Later in the year, Dr. Yancey and her husband got their shots, as did their children. But while most Americans now consider precautions like social distancing, wearing masks and quarantining after a Covid exposure optional, Dr. Yancey’s family still does all of them to keep her mother-in-law safe. (Sheikh, 11/22)


The Washington Post:
High Demand For Pediatric Beds Stresses System 


As the nation grapples with a surge in respiratory illnesses making very young children and babies ill, the high demand for inpatient and pediatric intensive-care-unit beds means children are spending days and weeks in emergency rooms designed for short-term evaluation and treatment. The surge has hit states in the East and Southeast particularly hard, with D.C., Maryland and Virginia reporting the highest incidence of influenza-like illness, which includes RSV, according to Centers for Disease Control and Prevention data. (Portnoy, 11/22)


Fox News:
New York Mom Whose Baby Struggled With RSV Has Urgent Message For Parents


A mother of five is asking parents to keep their sick children at home after a recent respiratory syncytial virus (RSV) outbreak infected three of her daughters and led to a frightening hospitalization for one of them. Carmen Bremiller, 27, of Barker, New York — in Broome County — has been caring for her daughters for several weeks and said the road to full recovery is ongoing. (Moore, 11/23)


Axios:
America Shrugs Off Its Twindemic


The much-feared twindemic — or even tripledemic — of respiratory viruses is here, but Americans are too COVID-fatigued to care. Flu in the southeast and RSV infections in multiple regions are filling up hospital wards and causing some facilities to cancel elective surgeries and bring back triage tents. (Bettelheim, 11/22)


AP:
States Move To Keep Court From Lifting Trump Asylum Policy 


A coalition of conservative-leaning states is making a last-ditch effort to keep in place a Trump-era public health rule that allows many asylum seekers to be turned away at the southern U.S. border. Late Monday, the 15 states filed what’s known as a motion to intervene — meaning they want to become part of the legal proceedings surrounding the public health rule referred to as Title 42. The rule, first invoked by Trump in 2020, uses emergency public health authority to allow the United States to keep migrants from seeking asylum at the border, based on the need to help prevent the spread of COVID-19. (Santana, 11/22)


Bloomberg:
Google Urged By US Lawmakers To Fix Misleading Abortion Ads


The lawmakers cited a joint analysis by Bloomberg News and the nonprofit Center for Countering Digital Hate, which found that ads displayed against Google searches such as “Planned Parenthood,” “Plan C pills” and “pregnancy help” didn’t carry labels that would indicate whether an advertiser was an abortion provider. (Love, 11/22)


NPR:
Why Doctors Don’t Openly Defy Abortion Laws, Even When Patients Are At Risk


“That’s just nuts,” Dr. Matthew Wynia says. He’s a physician who directs the Center for Bioethics and Humanities at the University of Colorado. “[A hysterotomy is] much more dangerous, much more risky – the woman may never have another pregnancy now because you’re trying to avoid being accused of having conducted an abortion.” (Risky, 11/23)


Modern Healthcare:
How Hospitals Can Cut Emissions, Achieve Net-Zero By 2050


The Health and Human Services Department branch recommends healthcare entities—particularly hospitals—establish systems to track and manage greenhouse gas emissions, appoint leaders to oversee progress, set goals and timelines, and invest in technology that measures their environmental impacts. (Hartnett, 11/22)


AP:
Over Half Of Mississippi’s Rural Hospitals Risk Closing 


Over half of Mississippi’s rural hospitals are at risk of closing immediately or in the near future, according to the state’s leading public health official. Dr. Daniel Edney, the state health officer, spoke to state senators at a hearing Monday about the financial pressure on Mississippi hospitals. Edney said 54% of the state’s rural hospitals — 38 — could close. The potential closures threaten to exacerbate poor health outcomes in one of the nation’s poorest states. (Goldberg, 11/22)


Reuters:
Generic Drugmakers Teva And Sandoz Make Major Push To Biosimilars


Generic drug makers Teva Pharmaceutical Industries and Sandoz say they are planning a significant ramp-up in production of biosimilars – copies of high-priced drugs used to treat illnesses such as rheumatoid arthritis and cancer – aiming to increase their share of an expanding market. More than 55 brand-name blockbuster biologic drugs, each with peak annual sales above $1 billion, are due to come off patent by the end of the decade, according to industry estimates. (Grover and Scheer, 11/22)


The New York Times:
Jail Is A Death Sentence For A Growing Number Of Americans 


Matthew Shelton was contending with diabetes and periodic substance abuse when he moved in with his sister outside Houston in order to get his life together. Three months later, facing an old criminal charge of driving while intoxicated, he turned himself in to the Harris County Jail one day in March with a supply of the insulin he relied on to stay alive. After two days, he told his family that no one was allowing him access to the insulin: He was trying to manage his illness by discarding the bread from the sandwiches he was served. He was alone, frightened and cold, he said. (Dewan, 11/22)


This is part of the KHN Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.



Source link

Ozinize
Logo
Shopping cart